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Pattern recognition receptors are used by cells to 
scan for intruding pathogens. Whereas a series   
of pattern recognition receptors like RIG-I–like   
helicases  and  NOD-like  receptors  are  present   
in the cytoplasm, Toll-like receptors (TLRs) are 
transmembrane  proteins  associated  with  either 
the plasma membrane or endosomes (Medzhitov, 
2008; Takeuchi and Akira, 2010; Yoneyama and 
Fujita, 2010). Pathogen-associated molecular pat-
terns like LPS are sensed by TLRs that are located 
at the plasma membrane. In contrast, nucleic acids 
from bacteria or viruses are sensed in acidified 
endosomes  (O’Neill,  2008).  Four TLR  family 
members have been found in endosomal com-
partments of immune cells, sensing double-
stranded  RNA  (TLR3),  single-stranded  RNA 
(ssRNA; TLR7/8),  and  nonmethylated  DNA 
(TLR9; Takeda  and  Akira,  2005).  Commonly 
used synthetic ligands to stimulate endosomal 
TLRs are Poly(I:C) for  TLR3, the ssRNA nucleo-
tide analogue imiquimod for TLR7, and non-
methylated  CpG-DNA  containing  ssDNA  for 
TLR9  (Takeda  and Akira,  2005). Accordingly,   
endosomal TLRs recognize pathogens by their 
genomes. For example, ssRNA viruses such as in-
fluenza virus and vesicular stomatitis virus (VSV) 
are recognized by TLR7, whereas DNA viruses 
are sensed by TLR9 (Lund et al., 2003, 2004; 
Diebold et al., 2004).
It is thought that stimulation of TLRs in-
duces a conformational change in receptor   
dimers associated with the formation of an 
intracellular  platform  able  to  recruit  adaptor 
CORRESPONDENCE  
Giulio Superti-Furga: 
gsuperti@cemm.oeaw.ac.at 
OR 
Sylvia Knapp: 
sylvia.knapp@meduniwien.ac.at
Abbreviations used: BMDC, 
BM-derived DC; BMDM, BM-
derived macrophage; FluAV, 
influenza A virus; IL-1R, IL-1 
receptor; KC, keratinocyte 
chemoattractant; LC, liquid 
chromatography; MOI, multi-
plicity of infection; MS, mass 
spectrometry; sCD14, soluble 
recombinant CD14; ssRNA, 
single-stranded RNA; TAP, 
tandem affinity purification; 
TLR, Toll-like receptor; VSV, 
vesicular stomatitis virus.
C.L. Baumann, I.M. Aspalter, and O. Sharif contributed 
equally to this paper.
I.M. Aspalter’s present address is Vascular Biology Laboratory, 
London Research Institute, Cancer Research UK, London. 
WC2A 3LY, England, UK.
CD14 is a coreceptor of Toll-like  
receptors 7 and 9
Christoph L. Baumann,1 Irene M. Aspalter,1 Omar Sharif,1,2  
Andreas Pichlmair,1 Stephan Blüml,3 Florian Grebien,1 Manuela Bruckner,1 
Pawel Pasierbek,4 Karin Aumayr,4 Melanie Planyavsky,1 Keiryn L. Bennett,1 
Jacques Colinge,1 Sylvia Knapp,1,2 and Giulio Superti-Furga1
1Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria
2Department of Medicine I, Division of Infectious Diseases and Tropical Medicine and 3Department of Medicine III, Division  
of Rheumatology, Medical University Vienna, 1090 Vienna, Austria
4BioOptics Facility, Research Institute of Molecular Pathology–Institute of Molecular Biotechnology of the Austrian Academy 
of Sciences, 1030 Vienna, Austria
Recognition of pathogens by the innate immune system requires proteins that detect 
conserved molecular patterns. Nucleic acids are recognized by cytoplasmic sensors as well 
as by endosomal Toll-like receptors (TLRs). It has become evident that TLRs require addi-
tional proteins to be activated by their respective ligands. In this study, we show that CD14 
(cluster of differentiation 14) constitutively interacts with the MyD88-dependent TLR7 
and TLR9. CD14 was necessary for TLR7- and TLR9-dependent induction of proinflamma-
tory cytokines in vitro and for TLR9-dependent innate immune responses in mice. CD14 
associated with TLR9 stimulatory DNA in precipitation experiments and confocal imaging. 
The absence of CD14 led to reduced nucleic acid uptake in macrophages. Additionally, 
CD14 played a role in the stimulation of TLRs by viruses. Using various types of vesicular 
stomatitis virus, we showed that CD14 is dispensable for viral uptake but is required for the 
triggering of TLR-dependent cytokine responses. These data show that CD14 has a dual role 
in nucleic acid–mediated TLR activation: it promotes the selective uptake of nucleic acids, 
and it acts as a coreceptor for endosomal TLR activation.
©  2010  Baumann  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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bind to TLRs in the endosome are involved in DNA ligand 
delivery such as HMGB-1, a histone-like protein, and LL37, a 
secreted antimicrobial peptide. These proteins are believed to 
convey DNA from dying cells to TLR9-containing endo-
somes (Lande et al., 2007; Tian et al., 2007). Because of the 
necessity of few TLRs to recognize a variety of structurally 
different ligands, it is reasonable to expect that ancillary pro-
teins concur in a modular and combinatorial fashion to   
ensure functional variety to the different TLR molecular ma-
chines (Gavin et al., 2006; Zak and Aderem, 2009).
RESULTS
An interaction proteomic approach identifies CD14  
as a partner of TLR7/9
The characterization of cellular protein complexes by purifica-
tion and mass spectrometry (MS) analysis has previously been 
successfully used to identify new components of signaling 
pathways in immunity both in a focused fashion and at a large 
scale (Kim et al., 2002; Andrejeva et al., 2004; Bouwmeester et al., 
2004; Häcker et al., 2006; Soulat et al., 2008). In this study, we 
sought to analyze protein complexes formed by the endosomal 
TLRs. To this end, we subjected the endosomal TLRs to the tan-
dem affinity purification (TAP)/MS procedure (Bürckstümmer   
et al., 2006; Köcher and Superti-Furga, 2007). TAP-tagged ver-
sions of endosomal murine TLR3, TLR7, TLR8, and TLR9 
were expressed in murine RAW264.7 macrophages by retro-
viral transduction (Fig. 1). Protein complexes of   TLRs were puri-
fied using a two-step purification protocol (Bürckstümmer   
et al., 2006). Eluates were analyzed by one-dimensional SDS-
PAGE, and the proteins were visualized by silver staining (Fig. 1 
and Fig. S1; Shevchenko et al., 1996). 20 slices were excised 
from each of the gel lanes, the proteins were digested in situ 
with trypsin (Shevchenko et al., 1996), and the peptides were 
extracted and analyzed by liquid chromatography (LC)– 
tandem MS (MSMS). All purifications were performed as bio-
logical duplicates and analyzed as technical duplicates (n = 4 for 
each TLR). Two strategies were used to obtain a confidence 
proteins important for intracellular signaling (Gay et al., 2006; 
Lin et al., 2010). TLR3 stimulation in macrophages and con-
ventional DCs, for instance, recruits the adaptor protein TRIF 
(TIR domain–containing adaptor-inducing IFN-), which 
leads to the TBK1 (Tank-binding kinase 1)–IRF3-dependent 
induction of type I IFNs as well as to the TRAF6-dependent 
induction of NF-B. However, in the same cells, the activa-
tion of TLR7 and TLR9 induces the recruitment of the 
adaptor MyD88, which by recruiting IRAK (IL-1 receptor 
[IL-1R]–associated kinase) kinases mediates the induction of 
proinflammatory cytokines. An additional pathway exists in 
plasmacytoid DCs, where TLR7 and TLR9 use MyD88 to 
induce high amounts of type I IFNs directly via the transcrip-
tion factor IRF7 (Blasius and Beutler, 2010).
Although the recently solved crystal structures of several 
TLR–ligand interfaces (Jin et al., 2007; Liu et al., 2008; Park 
et al., 2009) have aided our understanding for the molecular   
basis of pathogen recognition, the identity and role of pro-
teins participating to the fully functional TLR molecular ma-
chines have only been understood satisfyingly for the LPS   
receptor TLR4. This receptor requires the concerted action of 
at least four proteins, each of which is essential for LPS recog-
nition: LBP (LPS-binding protein), MD2, TLR4, and CD14 
(cluster of differentiation 14; Moore et al., 2000; Fitzgerald   
et al., 2004). CD14 is a glycosylphosphatidylinositol-anchored, 
membrane-associated protein that functions to aid the deliv-
ery of various ligands to TLRs, including LPS, lipoteichoic 
acid, ceramide, or Poly(I:C)/double-stranded RNA (Schmitz   
and Orsó, 2002; Lee et al., 2006; Akashi-Takamura and Miyake, 
2008). In addition, CD14 has been proposed to mediate the 
uptake of Poly(I:C) into TLR3-containing endosomes, thereby 
promoting TLR3 activation (Lee et al., 2006).
Two classes of cofactors have been described for the en-
dosomal TLRs: proteins of the ER are important for proper 
TLR localization and folding, such as the chaperones gp96/
Grp94, Prat4A, and Unc93B (Brinkmann et al., 2007; Akashi-
Takamura and Miyake, 2008). Other proteins that directly 
Figure 1.  Schematic illustration of the TLR interaction proteomic approach. Murine endosomal TLR3, TLR7, TLR8, and TLR9 were stably expressed in 
the macrophage cell line RAW264.7 by retroviral transduction. After TAP of the receptor complexes, eluates were analyzed by one-dimensional SDS-PAGE and 
silver stained. 20 gel slices were excised from each lane, the proteins were digested, and the peptides were analyzed by LC-MSMS. All bait TLRs were recovered 
with the average amount of peptides and sequence coverage as indicated in the table. At 55 kD, several peptides were identified from CD14. A schematic 
illustration of CD14 is depicted with the domains shown (signal peptide in red and leucine-rich repeats in blue) and the location of the identified peptides 
(black bars). For each TLR, the average number of peptides (av p.) identified and the sequence coverage (av%sc) of CD14 are indicated in the table.JEM VOL. 207, November 22, 2010 
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Coimmunoprecipitation and colocalization of CD14  
with endosomal TLRs
We  addressed  whether  the TAP/MS–detected  association 
could be confirmed by coimmunoprecipitation of V5-tagged 
TLRs  with  myc-tagged  CD14  from  double  transfected 
Hek293T cells (Fig. 2 A). CD14 bound to all four endosomal 
TLRs, showing the strongest association with the MyD88-
dependent TLR7, TLR8, and TLR9. In contrast, CD14 did 
not coprecipitate with IL-1R, which served as negative con-
trol. Differently migrating forms of CD14 (Fig. 2 A and see 
Fig. 5 A) may be attributed to different isoforms (soluble 
score for bona fide interactors. Semiquantitative information 
on identified proteins (peptide counts/sequence coverage) was 
used to compute enrichment of the protein over the initial cell 
lysate of RAW264.7 cells. In addition, specificity was calculated 
by statistical comparison with 1,000 unrelated protein com-
plex purifications and analyses in our laboratory. After applying 
these criteria, one of the identified high-confidence interactors 
present in all TLR-precipitations was CD14 (UniProtKB/
Swiss-Prot ID P10810, CD14_MOUSE). From four analyses, 
CD14 was identified with 7–10 peptides that correspond to a 
sequence coverage of 22.5–33.25% (Fig. 1 and Fig. S1 B).
Figure 2.  CD14 is an interactor of TLR3, TLR7, TLR8, and TLR9. (A) Myc-tagged CD14 was double transfected in Hek293T cells with either one  
V5-tagged endosomal TLR or V5–IL-1R as a negative control. 48 h after transfection, V5-tagged proteins were immunoprecipitated out of cell lysates 
using V5 agarose. Coprecipitation of CD14 was analyzed by Western blotting for myc and V5. IB, immunoblot. (B) Myc-CD14 was cotransfected with  
V5-TLR3, -TLR7, -TLR8, or -TLR9 into HeLaS3 cells. Colocalization was analyzed by confocal imaging. Representative areas of overlapping localization are 
shown magnified in the insets in the merge panel. (C) Images of a confocal section of endogenous CD14 and TLR9 in unstimulated RAW264.7 macro-
phages. (bottom) Quantification of three-dimensional colocalization analysis. Graph shows the percentage of pixels positive for CD14 colocalizing with 
pixels positive for TLR9 and the percentage of pixels positive for TLR9 colocalizing with pixels positive for CD14. (D) Colocalization analysis of the endo-
somal marker protein Eea1 and CD14 in unstimulated RAW264.7 macrophages. Data in A–D are representative of three independent experiments. Quanti-
tation in C is a mean of two independent experiments with each n = 600. Bars: (B) 10 µm; (C and D) 5 µm.2692 CD14: coreceptor of TLR7 and TLR9 | Baumann et al.
the  CD14-dependent  reduction  of  cytokines.  In  addition, 
quantitative real-time PCR analysis of CpG and imiquimod-
stimulated DCs (BMDCs) showed decreased levels of TNF and 
IL-6 messenger RNA levels in CD14-deficient cells as com-
pared with WT cells (Fig. 3 F).
To obtain further evidence for a role of CD14 in DNA 
recognition, we made use of a monoclonal antibody that selec-
tively blocks LPS binding to CD14 by competitive binding to 
the LPS-binding site on the ectodomain of CD14 (see Materials 
and methods). Imiquimod- and CpG-DNA–induced IL-6 
secretion was strongly reduced upon preincubation of both 
DCs and macrophages with the inhibitory antibody (Fig. 3 G 
and Fig. S4 A). This suggested competitive binding of the anti-
body and of imiquimod/CpG-DNA to the LPS-binding region 
of the CD14 ectodomain. Thus, CD14 is a critical cofactor for 
the recognition of imiquimod and DNA by the endosomal 
TLR7 and TLR9 ex vivo.
Because CD14 is important for LPS recognition, we rigor-
ously tested our stimuli for endotoxin contamination: a Limulus 
amebocyte lysate test showed no detectable endotoxin levels 
(Fig. S2 A). Addition of eritoran, a lipid A analogue which func-
tions as an LPS antagonist on TLR4 (Kim et al., 2007), was able 
to inhibit LPS-induced IL-6 secretion but did not affect 
imiquimod- or CpG-DNA–induced IL-6 cytokine production   
(Fig. S2 B). Similarly, using macrophages from TLR4-deficient   
mice, CpG-DNA–, imiquimod-, or Poly(I:C)-induced IL-6   
releases were similar in the absence of TLR4, whereas LPS- 
induced responses were abolished in cells lacking TLR4   
(Fig. S2 C). Moreover, challenge of TLR7-deficient DCs 
(BMDCs) with LPS and CpG-DNA but not with the TLR7 li-
gand imiquimod led to strong IL-6 production, arguing against 
endotoxin contamination of this ligand (Fig. S2 D). Collectively, 
these data strongly suggest that the blunted cytokine response in 
CD14-deficient cells stimulated with imiquimod or CpG-DNA 
was not caused by endotoxin contamination.
CD14 promotes CpG-DNA–induced inflammation in vivo
To test whether the induction of proinflammatory cytokines   
by CpG-DNA also required CD14 in vivo, we injected WT or 
CD14/ mice i.p. with CpG-DNA. Peritoneal lavage fluid was 
harvested 4 h after injection, and the accumulation of proinflam-
matory cytokines was analyzed. Consistent with the aforemen-
tioned results, CD14/ mice showed decreased IL-6 levels as 
compared with WT mice (Fig. 4 A). In addition, the levels of   
IL-1 and keratinocyte chemoattractant (KC; IL-8) were signif-
icantly reduced, whereas MCP-1 was unaltered. The cytokines 
KC and IL-1 are markers for neutrophil influx (Rogers et al., 
1994; Wengner et al., 2008), whereas MCP-1 is involved in the 
regulation of macrophage recruitment (Takahashi et al., 2009). 
To test whether the reduction in cytokine levels was reflected in 
immune cell recruitment into the peritoneal cavity, we measured 
neutrophil and macrophage influx into the peritoneum of WT   
and CD14-deficient mice after CpG stimulation. CD14/ mice 
exhibited lower amounts of neutrophils compared with WT 
mice upon CpG-DNA challenge, whereas the numbers of mac-
rophages were not changed (Fig. 4 B). We concluded that CD14   
CD14/membrane-bound  CD14)  and  have  been  observed 
previously (von Schlieffen et al., 2009).
We  further  tested  physical  proximity  of  epitope-tagged 
CD14 and endosomal TLRs by confocal imaging of transfected 
HeLa cells (Fig. 2 B). CD14 clearly colocalized with the 
MyD88-dependent TLR7, TLR8, and TLR9 (Fig. 2 B) but less 
for TLR3 (Fig. 2 B). We next addressed whether colocalization 
could also be observed by analyzing endogenous CD14 and 
TLR9. Therefore, we chose to use mouse RAW264.7 macro-
phages that are known to be competent for TLR signaling.   
Indeed, the endogenous proteins colocalized in nonstimulated 
cells (Fig. 2 C, top). Quantitation of colocalized pixels of CD14 
and TLR9 in >600 cells revealed that 82% of detected CD14 
was present in the same areas as TLR9, and, vice versa, 54% of 
TLR9 colocalized to the same region as CD14 (Fig. 2 C, bot-
tom). We did not observe changes in this localization pattern 
upon stimulation with different ligands (unpublished data).   
By costaining for the endosomal marker Eea1, we addressed 
whether CD14 would colocalize to endosomal compartments 
in unstimulated cells (Fig. 2 D) and indeed observed significant 
co-distribution. Thus, CD14 is a constitutive endosomal protein 
that associates with all endosomal TLRs in unstimulated cells.
CD14 promotes CpG-DNA and imiquimod recognition  
in Hek293-TLR9 and in isolated mouse immune cells
Next, we set out to explore the functional consequences of the 
association between CD14 and TLR7 and TLR9. First, we tested 
whether Hek293 cells that express TLR9 but not CD14 can be 
modulated in their proinflammatory cytokine response by the 
addition of soluble recombinant CD14 (sCD14) to the medium. 
sCD14 alone did not induce cytokine secretion (Fig. 3 A).   
As expected, CpG-DNA elicited low but detectable levels of 
IL-8. Intriguingly, this CpG-DNA response could be amplified 
up to fourfold by exogenous addition of sCD14 (Fig. 3 A).   
We conclude that sCD14 has the ability to sensitize cells for 
DNA recognition by TLR9.
Having established that sCD14 positively impacted DNA 
recognition via TLR9, we tested whether loss of CD14 would 
affect cytokine responses after TLR stimulation. For this pur-
pose, we analyzed the induction of proinflammatory cytokines 
in macrophages and DCs derived from WT or CD14-deficient 
(CD14/)  mice  that  were  treated  with TLR  ligands. The 
TLR7 and TLR9 ligands imiquimod and CpG-DNA, respec-
tively, elicited less IL-6 in CD14-deficient BM-derived DCs 
(BMDCs) and BM-derived macrophages (BMDMs) as com-
pared with WT cells (Fig. 3, B and C; and Fig. S3). As shown 
previously (Moore et al., 2000), LPS-induced IL-6 secretion 
was completely abrogated in CD14-deficient cells (Fig. S3). 
Importantly, stimulation with Taxol, a ligand for TLR4 which 
does not require CD14 (Kawasaki et al., 2000; Zanoni et al., 
2009), resulted in equal amounts of IL-6 in WT and CD14/ 
BMDCs (Fig. 3 D). Similarly, DMXAA, a compound which 
activates the TBK1–IRF3 pathway via a yet unclear mechanism 
(Roberts et al., 2007), induced almost equal amounts of type I 
IFN in peritoneal macrophages (Fig. 3 E) and IL-6 in BMDCs 
(see Fig. 6 G), indicating integrity of the cells and specificity of JEM VOL. 207, November 22, 2010 
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previously been reported to bind to and promote the phago-
cytic uptake of Poly(I:C) (Lee et al., 2006), and thus, a similar 
role  for  CD14  in  DNA  binding  and  endosomal  delivery 
could be anticipated. To test this, we first asked whether CD14 
has affinity for CpG-DNA. We precipitated endogenous 
CD14 from RAW264.7 macrophages with streptavidin beads 
that were coated with biotinylated CpG-DNA, GpC-DNA, 
or LPS (Fig. 5 A). Trex1, a known DNA-binding protein   
is necessary for the proinflammatory response to CpG-DNA   
in vivo, which is consistent with its role as a cofactor of TLR9.
CD14 associates with CpG-DNA and is required  
for its phagocytic uptake
One possible explanation for the decreased cytokine response 
in CD14-deficient cells could be reduced delivery of the li-
gand into TLR-containing endosomal compartments. CD14 has 
Figure 3.  CD14 is required for the proinflammatory response to imiquimod and CpG-DNA. (A) Hek293-TLR9 cells were preincubated with the 
indicated concentrations of sCD14 30 min before stimulation with 1 µM CpG or mock control (no). Culture supernatants were harvested 8 h later, and the 
levels of human IL-8 were determined. Data are presented as mean ± SD and are representative of two independent experiments, each performed in bio-
logical duplicates. (B–D) BMDCs (B and D) or BMDMs (C) from WT or CD14/ mice were stimulated with CpG-DNA, imiquimod (IMQ), or Taxol for 6 h.  
IL-6 in supernatants was measured by ELISA. Data are presented as mean ± SD. (E) Peritoneal macrophages were stimulated with Poly(I:C) or DMXAA for 
16 h, and type I IFN levels were determined using the IFN luciferase reporter cell line LL171. (F) BMDCs were stimulated for 3 and 6 h as indicated. TRIZOL-
extracted RNA was reverse transcribed and used for quantitative real-time PCR to analyze the abundance of transcripts encoding TNF and IL-6. (G) BMDMs 
from WT mice were incubated with a CD14-specific inhibitory antibody (AB) where indicated 30 min before stimulation with LPS, imiquimod, or CpG-DNA. 
After 12 h of stimulation, culture supernatants were harvested, and IL-6 protein was measured by ELISA. Data are presented as mean ± SD and are  
representative of at least three independent experiments, each performed in biological triplicates.2694 CD14: coreceptor of TLR7 and TLR9 | Baumann et al.
suggest that CD14 promotes the selective uptake of DNA 
into the endosome.
CD14 is dispensable for virus uptake but required  
for virus recognition
Unlike  free-floating  synthetic  ligands,  pathogen-associated   
DNA and RNA are released only in the late endosome/lysosome   
because of the acidification and activity of proteases (Blasius 
and Beutler, 2010). We asked whether CD14-dependent   
induction of proinflammatory cytokines would entirely be 
attributable to defective uptake of TLR agonists or whether 
CD14 has a more promiscuous role in endosomal recognition 
of nucleic acids by TLR7/9. To distinguish between these two 
hypotheses, we decided to use influenza A virus (FluAV) and 
VSV, which are both taken up by an active cellular process 
and are sensed by TLR7 in the endosome (Diebold et al., 
2004; Lund et al., 2004). Uptake and replication of VSV bear-
ing a green fluorescently tagged glycoprotein was indistin-
guishable in CD14-deficient and WT peritoneal macrophages 
(Fig. 6 A). Furthermore, supernatants from VSV-infected WT 
and CD14/ macrophages (Fig. 6 B) and BMDCs (Fig. S6 A) 
contained similar amounts of infectious particles, suggesting 
that virus growth was not changed in CD14-deficient cells. 
However, FluAV- and VSV-infected CD14-deficient perito-
neal macrophages generated less IL-6 and type I IFN as com-
pared  with WT  control  cells  (Fig.  6,  C  and  D).  Equally, 
BMDCs from CD14/ mice produced much less IL-6 than 
WT control cells. This blunted cytokine response in CD14-
deficient cells was strongest for VSV and weaker but still sig-
nificant after infection with FluAV (Fig. 6, C–E). Similarly, 
IL-6 responses induced by both viruses were strongly inhib-
ited in the presence of the CD14 antibody but not when an 
isotype control was used (Fig. S6 B). These data suggest that 
CD14 is dispensable for the uptake of pathogens but impor-
tant for their ability to stimulate proinflammatory cytokines.
(Stetson et al., 2008), served as control. Western blot analysis 
of precipitated material showed that CD14 was significantly 
enriched on beads that were coupled with either DNA spe-
cies, indicating that CD14 associates with DNA. The LPS 
control  precipitated  CD14  as  well,  as  expected.  Similarly, 
peritoneal  macrophages  from  CD14/  mice  that  were 
shifted to 4°C to inhibit active phagocytosis showed 50% 
reduction in DNA association as compared with WT control, 
suggesting that CD14 promotes the binding of DNA to the 
plasma membrane (Fig. S5).
However, the association of CD14 with DNA could be me-
diated by other proteins and thus might be indirect. Therefore, we 
tested for a direct association of CD14 with DNA in an ELISA-
based assay. Recombinant CD14-Fc chimera bound to CpG-
coated plates, and this association could be blocked by using 
LPS as competitor (Fig. 5 B). This suggests that CD14 binds to 
CpG-DNA directly and indicates that LPS and CpG-DNA 
might bind to overlapping regions on CD14, which was already 
suggested by the antibody inhibition experiments (Fig. 3 G).
A CD14–DNA interface could be required for the active 
transport of free nucleic acids into the TLR-containing endo-
some. Fluorescently labeled CpG-DNA that was added to the 
culture medium of RAW264.7 macrophages colocalized with 
endogenous  CD14  and  the  endosomal  markers  Eea1  and 
Lamp1 (Fig. 5 C and Fig. S4 B). These results suggest an asso-
ciation of CD14 with CpG-DNA in endosomal compart-
ments. Moreover, when we compared the uptake of fluorescent 
DNA by WT and CD14/ peritoneal macrophages after   
30 min and 2 h (Fig. 5 D), an impaired internalization of 
CpG-DNA was observed in cells lacking CD14 as compared 
with control cells. This suggests that the process of DNA/ 
nucleic acid internalization is partly dependent on CD14. 
Importantly, there was no difference between WT and CD14-
deficient thioglycolate-elicited macrophages in the uptake of 
heat-killed Escherichia coli (Fig. 5 E). In summary, these results 
Figure 4.  CD14 is important for the  
proinflammatory response to CpG-DNA  
in vivo. WT or CD14/ mice were i.p. injected 
with 8 nmol CpG-DNA. After 4 h, mice were 
sacrificed. (A) The levels of the proinflamma-
tory cytokines IL-6, KC (IL-8), IL-1, and MCP-1 
in peritoneal lavage were analyzed by ELISA. 
(B) Peritoneal lavage was taken, and total 
cells, neutrophils, and macrophages were 
counted. Differences in cytokine values of WT 
and CD14/ stimulation pairs were tested for 
significance using the one-way analysis of 
variance and Tukey’s post test. Significant 
alterations in pattern are marked with an 
asterisk (*, P < 0.05 vs. WT mice; Mann– 
Whitney T test). In A, P = 0.0434, P = 0.0005, 
and P = 0.0029 for IL-6, IL-8, and IL-1, re-
spectively. In B, P = 0.0002 for neutrophils. 
Data are presented as mean ± SD and are 
representative of two independent experi-
ments, each performed with eight mice/group.JEM VOL. 207, November 22, 2010 
Article
2695
require CD14 for cytokine induction. 
To test this hypothesis, we used a mu-
tant version of VSV (VSV-M2), which 
bears a point mutation in the  VSV ma-
trix protein that serves as suppressor of the cytoplasmic rec-
ognition pathway in the WT virus (Stojdl et al., 2003). As 
expected, after VSV-M2 infection, TLR7-deficient and WT 
cells generated comparable amounts of IL-6 (Fig. 6 F), proba-
bly  elicited  through  activation  of  the  cytoplasmic  sensor 
RIG-I (Kato et al., 2006). We next used this virus to stimulate 
CD14-deficient as well as WT BMDCs and peritoneal macro-
phages. As shown in Fig. 6 (C and E), VSV required CD14 
for proper induction of IL-6 (Fig. 6 G and Fig. S6 C). In con-
trast, VSV-M2 induced similar levels of IL-6 in CD14/ and 
WT BMDCs (Fig. 6 G and Fig. S6 C). Collectively, these data 
strongly suggest that CD14 is required for TLR-dependent 
recognition of viruses but is dispensable for the induction of 
proinflammatory  cytokines  in the cytoplasmic sensing of   
virus infection.
DISCUSSION
CD14 is a well established component of the protein com-
plexes conferring ligand binding and signaling competence to 
the cell surface–expressed TLR4 (Ulevitch and Tobias, 1999). 
Unlike defined synthetic ligands, viruses can activate mul-
tiple pathways, including the TLR and the cytoplasmic RIG-like 
receptor pathway. Therefore, we tested whether IL-6 production 
in response to VSV and FluAV depends on TLR activation. We 
could partially inhibit  VSV- and FluAV-induced IL-6 in BMDCs 
by applying z-FA-FMK (benzyloxycarbonyl–phenyl-alanyl– 
fluoromethylketone), a cysteine protease inhibitor which blocks 
endosomal cathepsin activity and thereby inhibits full activation 
of endosomal TLRs (Park et al., 2008). In contrast, LPS-induced 
IL-6 levels were unaltered by this drug, suggesting that VSV and 
FluAV recognition depended on the activation of endosomal 
TLRs (Fig. S6 D). As z-FA-FMK could additionally affect the 
degradation of viral particles in the endosome and therefore 
could reduce the amount of nucleic acid ligand, we proved that 
VSV is indeed recognized by TLR7 because TLR7-deficient 
BMDCs only generated minimal amounts of IL-6 after stimula-
tion with VSV (Fig. 6 F).
We established that TLR7 requires CD14 for proper 
activation and hypothesized that a virus that is recognized   
by TLR7-independent  mechanisms  should  therefore  not 
Figure 5.  Association of CD14 with DNA 
is required for DNA internalization and  
IL-6 induction. (A) Lysates from untreated 
RAW264.7 macrophages were incubated for  
2 h with streptavidin beads that were coated 
with either biotinylated LPS or biotinylated 
CpG-DNA or with GpC-DNA. After four wash 
steps, bead-bound CD14 or a DNA-binding 
protein control (Trex1) was visualized by 
Western blotting. (B) For ELISA-based assay, 
CpG-DNA–coated ELISA plates were incubated 
with a soluble CD14-Fc chimera and LPS as 
competitor. Absorbance of anti–mouse horse-
radish peroxidase antibody indicates DNA-
bound CD14. Data are mean ± SD. (C) 1 µM 
cy3-CpG-DNA was added to the culture me-
dium of RAW264.7 macrophages. CD14 colo-
calization with endocytosed fluorescent DNA 
was visualized by immunostaining and ana-
lyzed by confocal imaging. Bar, 5 µm. (D) 1 µM 
cy3-CpG-DNA was added to the supernatant 
of WT- or CD14/-derived peritoneal macro-
phages for the indicated time periods (x axis). 
The uptake of fluorescent DNA by F4/80-
positive macrophages was measured by FACS 
analysis and depicted as phagocytic index  
(y axis). (E) The uptake of heat-killed E. coli  
by thioglycollate-elicited peritoneal macro-
phages of WT and CD14/ mice was tested 
and depicted as phagocytic index. Data in E 
are presented as mean ± SD. All experiments 
in A–E are representative of at least two inde-
pendent experiments.2696 CD14: coreceptor of TLR7 and TLR9 | Baumann et al.
Figure 6.  CD14 is dispensable for virus uptake but required for the induction of cytokines in ssRNA virus-infected macrophages. (A) Perito-
neal macrophages from WT or CD14/ mice were infected with VSV that expresses a GFP-fused glycoprotein (VSV-GFP; MOI: 1) and analyzed by FACS. 
The histogram shows GFP positivity of uninfected cells (dashed lines) or cells that were infected for either 4 or 6 h (solid lines). Cells were gated on  
forward and sideward scatter. (B) Virus accumulation in supernatant of BMDMs that were infected with VSV (MOI: 1) for the indicated time periods.  
The graph shows the mean virus titer from three independent experiments. Data are mean ± SD. (C–E) Accumulation of IL-6 or type I IFN 14 h after  
infection of WT and CD14-deficient peritoneal macrophages (C and D) or BMDCs (E) with the indicated MOI of VSV and FluAV or stimulated with LPS.  
(F and G) BMDCs from WT or TLR7-deficient (F) or WT and CD14-deficient (G) mice were infected with the indicated amounts of VSV or VSV-M2, a mutant 
which is mainly recognized in the cytoplasm, or stimulated with imiquimod, LPS, or DMXAA. IL-6 accumulation was tested 14 h after stimulation. Data in C–G 
are presented as mean ± SD and are representative of at least two independent experiments. (H) The model shows that CD14 associates with DNA/ssRNA at JEM VOL. 207, November 22, 2010 
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data suggest that, even in the total absence of CD14, phago-
cytes still internalize 60% of DNA compared with their WT 
counterparts (Fig. 5 D). This suggests that CD14 contributes 
but may not be strictly necessary for DNA uptake.
We show that the uptake of heat killed E. coli and ssRNA   
viruses, which are internalized similarly to nucleic acids (Sun   
et al., 2005), does not require CD14 (Figs. 5 E and 6 A). Also, virus 
growth was indistinguishable in CD14/ and WT cells, sug-
gesting that uptake of viral pathogens is independent of CD14 
(Fig. 6 B and Fig. S6 B). Functional dependence on TLRs for the 
recognition of ssRNA allowed for the investigation of CD14-
dependent TLR activation without the complication of reduced 
ligand uptake. TLR7 signal induction by ssRNA viruses un-
equivocally required CD14 in both macrophages and DCs. The 
requirement of CD14 for induction of proinflammatory cyto-
kines after virus challenge could be rescued using the VSV-M2 
mutant, which is sensed by the cytoplasmic recognition 
machinery. These data strongly suggest a selective role of CD14 
in endosomal but not cytosolic recognition of ssRNA viruses. 
Given that CD14 appeared to be a constitutive interactor of   
endosomal TLRs even in unstimulated cells, we believe that 
CD14 functions as a coreceptor for endosomal TLRs.
CD14 was also involved in the induction of type I IFN 
in peritoneal macrophages (Fig. 6 D). As the activation of 
TLR7/9 in macrophages is believed to exclusively trigger the 
MyD88-dependent induction of proinflammatory cytokines 
(Blasius and Beutler, 2010), it is possible that CD14 has, in 
addition to its function as a TLR coreceptor, a role in the 
cytoplasmic induction of type I IFNs in macrophages. MAVS 
(mitochondrial antiviral signaling protein), a platform for cyto-
plasmic RNA receptors, exerts signaling from the mem-
branes of different cellular organelles (Dixit et al., 2010), and 
thus, it is tempting to speculate that the membrane-associated, 
glycosylphosphatidylinositol-anchored CD14 could be in-
volved in the organization of those membrane rafts. In sum-
mary, we suggest two roles for CD14 in endosomal TLR 
activation: (1) a function in the selective nucleic acid uptake and 
(2) a function as a coreceptor of TLR7 and TLR9 (Fig. 6 H).
In the future, it will be important to further dissect the ac-
tivities of CD14 in the endosomal recognition of pathogens. 
Urgent questions to be addressed are how CD14 grants ligand 
sensitivity to endosomal  TLRs and how the LPS-binding pocket 
contributes to this. CD14 could contribute to the engagement 
of nucleic acids by a holo-receptor in analogy to LPS recogni-
tion by the TLR4–CD14 complex (Fitzgerald et al., 2004).   
Alternatively, CD14 might act indirectly by providing a physical 
platform for the recruitment of factors required to assemble a 
fully functional receptor complex (Schmitz and Orsó, 2002).
The  finding  that  CD14  is  required  for  both  ssRNA/ 
imiquimod as well as DNA recognition by TLR7 and TLR9 
offers the possibility that CD14 contributes to DNA-mediated   
immunization and autoimmune processes. Free host DNA 
Itself a protein containing leucine-rich repeats, as the TLRs, it 
shares some of the structural and ligand-binding properties of 
TLRs and, in the case of LPS, may appear to act as a dimeric 
TLR coreceptor, effectively enhancing the ability of TLR4   
to be triggered by LPS. The three-dimensional structure of 
CD14 is known, and together with mutational analysis, it has 
been possible to locate the LPS-binding region in the N ter-
minus of a horseshoe-like structure (Kim et al., 2005). We 
have identified CD14 as interactor of all four endosomal TLRs. 
Our data extend the current list of receptors that require 
CD14 for proper function to add the MyD88-dependent TLR7 
and TLR9 and thus establish a wider role for CD14 in innate 
immunity. We provide a series of experiments, including a 
mouse model, that show that CD14 is involved in the recog-
nition and subsequent innate immune response to the ligands 
DNA and imiquimod/ssRNA.
It is interesting to note that CD14 has been shown to 
bind a whole variety of microbial products through overlap-
ping but not identical portions of the molecule (Pugin et al., 
1994; Kim et al., 2005). We now show that CD14 is not only 
associated with TLR7 and TLR9 but also engages their ligands. 
LPS and CpG-DNA appeared to compete for binding to   
recombinant CD14 in vitro, and nucleic acid–induced cytokine 
production was inhibited by antibodies that recognize the LPS-
binding portion of CD14, suggesting that the N-terminal do-
main of CD14 may also be involved in nucleic acid recognition 
(Kim et al., 2005). This notwithstanding, the common region 
involved in binding could at the same time mediate inter-
action with different coreceptor proteins. How a full or partial 
recognition of nucleic acids by CD14 complements the nucleic 
acid binding of endosomal TLRs will be an interesting sub-
ject of further studies.
A requirement for CD14 in Poly(I:C) ligand endocytosis 
for  efficient TLR3-mediated  cytokine  induction  has  been   
reported previously (Lee et al., 2006). This, together with our 
uptake assays, suggests that CD14 has a role in enhancing the 
selective internalization of different nucleic acids, which in 
turn promotes their active delivery to TLR-containing endo-
somes. CD14-dependent shuttling processes have been the 
object of previous studies and allowed for the attribution of 
further roles to CD14, including clearance of endotoxin 
(Dunzendorfer et al., 2004), Golgi trafficking of the TLR4 
receptor complex (Latz et al., 2002), and the internalization of 
the TLR2 ligand FSL-1 after signal induction (Shamsul et al., 
2010). This suggests a dual function of CD14 in the uptake as 
well as trafficking of ligands and receptor complexes, so far for 
plasma membrane–associated TLRs.
A previous functional study on Poly(I:C) uptake and 
TLR3 colocalization showed a strict requirement for CD14 
in reconstituted Chinese hamster ovary cells (Lee et al., 2006). 
In this study, we tested the uptake of nucleic acids/DNA in 
primary murine CD14-deficient phagocytes. Interestingly, our 
the plasma membrane and promotes their endocytosis. ssRNA viruses enter the endosome in a CD14-independent way. Acidification destroys the viral 
envelope, releasing the viral ssRNA genome. In the endosome, CD14 functions as a coreceptor for TLR7 and TLR9 in the recognition of ssRNA and DNA.
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hTLR7, NM_016562; hTLR8, NM_138636; and hTLR9, NM_017442) 
and mCD14 (available from GenBank under accession no. NM_009841) 
were cloned from InvivoGen vectors (pUno-HA vectors). Human IL-1R 
(available from GenBank under accession no. NM_000877.2) and CD14 
(available from GenBank under accession no. NM_000591) were amplified 
from a human testis cDNA library (Takara Bio Inc.) using the following 
primers:  CD14  5,  5-GGGGACAAGTTTGTACAAAAAAGCAGG-
CTCCATGGAGCGCGCGTCCTGCTTGTTGCTGCTG-3;  CD14  3,   
5-GGGGACCACTTTGTACAAGAAAGCTGGGTTTAGGCAAAGCC-
CCGGGCCCCTTGGAGC-3;  IL-1R  5,  5-GGGGACAAGTTTGTAC-
AAAAAAGCAGGCTCCATGAAAGTGTTACTCAGACTTATTTG-3; 
and IL-1R 3, 5-CCCGAGAGGCACGTGAGCCTCTCTTTGGGGG-
ACCACTTTGTACAAGAAAGCTGGGTT-3. All  gateway  entry  clones 
for C-terminal tagging of full-length cDNAs were created using 20–25 bp of 
flanking regions and the following gateway primer sequences: sense attB1 
primer,  5-GGGGACAAGTTTGTACAAAAAAGCAGGCTAGACTGC-
CATG(NNN)5–10-3; and antisense attB1 primer, 5-GGGGACCACTTTG-
TACAAGAAAGCTGGGTTNOSTOP(NNN)10–15-3. Gateway LR Clon-
ase (Invitrogen) target vectors for protein expression were pTracer-V5 (Invit-
rogen), pcDNA6myc, and pCeMM CTAP(SG).
Cell culture and viruses. Cell lines used were RAW264.7 murine macro-
phages, Hek293, Vero, and HeLaS3 cells. Cells were cultured in DME (PAA) 
supplemented with 10% FCS (Invitrogen) and antibiotics (100 U/ml penicillin 
and  100  µg/ml  streptomycin)  at  37°C,  5%  CO2.  BM  was  retrieved  from 
C57BL/6J (breeding facility of the Medical University of Vienna, Vienna, Aus-
tria) and B6.129S-Cd14tm1Frm/J CD14/ (The Jackson Laboratory) by flushing 
the tibia and femur with RPMI (PAA). BMDMs were obtained by differentiat-
ing BM in RPMI supplemented with 10% FCS, 1% penicillin and streptomycin 
(Pen/Strep), and 20 ng/ml M-CSF for 7 d. BMDCs were obtained by differen-
tiating BM with RPMI supplemented with 10% FCS, 1% Pen/Strep, 20 ng/ml 
GM-CSF,  and  50  µM  -mercaptoethanol.  Primary  peritoneal  macrophages 
were obtained using peritoneal lavage with 5 ml of sterile saline. Lavage fluid was 
collected in sterile tubes and placed on ice. Peritoneal macrophages were resus-
pended in RPMI supplemented with 10% FCS and 1% Pen/Strep at the appro-
priate cell density and allowed to adhere overnight. 1 h before stimulations, all 
primary cells were washed twice with serum-free medium and retaken in RPMI 
without FCS to avoid cell reconstitution with serum-derived soluble CD14.
For influenza virus production, Vero cells were cultured in VP-SFM   
serum-free medium (Invitrogen) in the presence of 3 µg/ml trypsin (Sigma- 
Aldrich). Influenza A/PR/8/34 was propagated on Vero cells adapted from   
serum-free medium and supplemented with 3 µg/ml trypsin. Semliki forest virus 
(a gift from I. Kerr, Cancer Research UK, London, England, UK), VSV (strain: 
Indiana; a gift from F. Weber, University Hospital Freiburg, Freiburg, Germany), 
and the VSV-M2 mutant strain (provided by J. Bell and U. Kalinke) were grown 
on Vero cells under standard conditions, and virus stocks were titrated by plaque 
assay on Vero cells.
C57BL/6J mice were obtained from the breeding facility of the Medical 
University  of Vienna,  and  B6.129S-Cd14tm1Frm/J  CD14/  were  ordered 
from The Jackson Laboratory. BM of mice originally generated in the lab of 
S. Akira (Osaka University, Suita, Osaka, Japan) was provided by C. Lassnig 
(University of Veterinary Medicine, Vienna, Austria; TLR4/) and by   
B. Drobits and M. Sibilia (Medical University of Vienna; TLR7/). The BM 
was retrieved by flushing the tibia and femur with RPMI (PAA). BMDMs 
were obtained by differentiating BM in RPMI supplemented with 10% FCS, 
1% Pen/Strep, and 20 ng/ml M-CSF for 7 d.
Total IFN-/ was measured by titration on LL171 cells and compared 
with recombinant IFN- used as a cytokine standard (Habjan et al., 2009).   
To measure VSV growth on primary cells, BMDMs and BMDCs were in-
fected with  VSV (multiplicity of infection [MOI]: 1), and accumulation of in-
fectious virus after 24 and 48 h was measured by serial dilution on Vero cells.
RT-PCR. RNA from primary cells for quantitative real-time PCR analysis 
was extracted using TRIZOL. 100 ng RNA/sample was reversely tran-
scribed using reagents/RT (Fermentas). cDNA was diluted 1:20, and transcript   
that can cause the development of autoantibodies and con-
tributes to diseases like systemic lupus erythematosus has been 
linked  to TLR9  (Krieg  and Vollmer,  2007).  For  instance, 
HMGB-1, although not membrane associated, binds and en-
hances nucleic acid uptake into the endosome, such that a role   
in autoimmunity has been suggested (Tian et al., 2007). We 
speculate that CD14 levels affect endosomal TLR-mediated 
adjuvant effects and thus may impact certain anticancer thera-
pies or antiviral responses.
MATERIALS AND METHODS
Reagents. ELISA kits were purchased from BD. The Limulus amebocyte   
lysate endotoxin test was purchased from Cambrex Bio Science Verviers.   
Murine GM-CSF and M-CSF were purchased from PeproTech. Taxol was 
obtained from Sigma-Aldrich. z-FA-FMK was purchased from Sanova. All 
synthetic TLR ligands, Poly(I:C), imiquimod, CpG-DNA-ODN1826, CpG-
DNA-ODN1585, and LPS (E. coli K12) as well as biotinylated LPS and 
Hek293-TLR9 cells were obtained from InvivoGen. Biotinylated and cy3- 
labeled oligonucleotides were synthesized at Microsynth. Protein G–Sepharose 
was purchased from GE Healthcare, and streptavidin beads were purchased 
from Thermo Fisher Scientific. Rat anti-CD14 antibody was obtained from 
BD, and mouse anti-V5 antibody was obtained from Invitrogen. Rabbit anti-
myc was purchased from Sigma-Aldrich, mouse anti-TLR9 was purchased 
from Imgenex (IMG-305A), mouse anti-Lamp1 was purchased from Stress-
gen, and mouse anti-Eea1 was purchased from BD. Inhibitory CD14 antibody 
Big53 and endotoxin-free recombinant, soluble murine and human CD14 
were purchased from Biometec (http://www.biometec.de/index.php?id=137), 
recombinant Fc-CD14 chimera was obtained from R&D Systems. F4/80 anti-
body was obtained from Abcam, and CD86 and CD11c antibodies were ob-
tained from BD. All secondary antibodies were purchased from Invitrogen 
(Alexa Fluor 488, 546, 594, 680, and 800 nm). RT-PCR reagents were bought 
from GeneXPress, and buffers were bought from Sigma-Aldrich.
MS sample preparation. Samples were alkylated with iodoacetamide and 
separated by one-dimensional SDS-PAGE on a 4–12% bis-Tris gel (NuPAGE; 
Invitrogen). After visualization of the proteins by silver staining, entire lanes 
were excised into 20 pieces and digested in situ with modified porcine trypsin 
(Promega) essentially as described by Shevchenko et al. (1996). Before analysis 
by nano-LC–electrospray ionization–MSMS, peptides were purified and con-
centrated via customized reversed-phase columns adapted from Rappsilber   
et al. (2003).
MS and data analysis. Tryptically digested samples were analyzed by data-
dependent nanocapillary reversed-phase LC-MSMS using customized 50 µm 
i.d. × 16 cm analytical column packed with C18 3-µm diameter Reprosil beads 
(Maisch) on a nano-LC system (1200 series; Agilent Technologies) coupled to 
a hybrid mass spectrometer (LTQ-Orbitrap; Thermo Fisher Scientific). Data-
dependent acquisition was performed for 100 min using one MS channel for 
every four MSMS channels and a dynamic exclusion for selected ions of 60 s.
The acquired data were processed and searched against the mouse IPI data-
base version 3.41 with the search engine MASCOT (Matrix Science). Submis-
sion to the search engine was via a Perl script that performs an initial search with 
relatively broad mass tolerances on both the precursor and fragment ions 
(±10 ppm and ±0.6 D, respectively). High-confidence peptide identifications 
were used to recalibrate all precursor and fragment ion masses before a second 
search with narrower mass tolerances (±4 ppm and ±0.3 D). A false-positive de-
tection rate of <1% was estimated by searching the dataset against a reversed data-
base. Criterion for a positive protein identification was detection of peptides with 
≥6 aa and a minimum of two peptides with a MASCOT peptide score of ≥20.
Plasmids. All constructs were cloned using the gateway system. Murine and 
human TLR constructs (available from GenBank/EMBL/DDBJ under the 
following  accession  nos.:  mTLR3,  NM_126166;  mTLR7,  NM_133211; 
mTLR8,  NM_133212;  mTLR9,  NM_031178;  hTLR3,  NM_003265; JEM VOL. 207, November 22, 2010 
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Immunofluorescence analysis. For colocalization analysis, HeLaS3 cells were 
plated on coverslips at a density of 3 × 105/well on a 6-well plate. 24 h later, 
cells were transfected with 1 µg human CD14-myc and 1 µg human TLR-V5 
construct using Lipofectamine (QIAGEN). 24 h later, cells were washed and 
fixed with 4% PFA/PBS for 10 min at room temperature. After three washes 
with PBS, slides were permeabilized with 0.1% Triton/PBS for 10 min. Then, 
coverslips were blocked with 3% BSA/PBS for 30 min, and incubations with 
primary and secondary antibody were each performed for 1 h in 3% BSA/PBS 
at room temperature. Primary antibodies were stained with the fluorescence-
coupled antibodies Alexa Fluor 488–goat anti–rabbit (A11008) and Alexa Fluor 
594–goat anti–mouse (A11005; both from Invitrogen). DNA was visualized   
by DAPI (Roth). After another three wash steps with PBS, coverslips were 
mounted on glass slides using ProLong Gold (Invitrogen). Stainings of endoge-
nous proteins in RAW264.7 macrophages were performed equally, except that 
direct primary antibodies binding to the respective proteins were used. The lo-
calization of proteins was analyzed using a confocal microscope (LSM510; Carl 
Zeiss, Inc.), equipped with the 63× numerical aperture 1.4 Plan-Apochromat 
lens. DAPI was excited with the 405-nm laser line and the emitted fluorescent 
light was detected in the range of 420–470 nm. Green represents fluorescent 
signal collected in the range of 505–550 nm upon excitation with a 488-nm laser. 
Red corresponds to a signal in the range of 575–620 nm and resulted from   
561-nm excitation. Confocal stacks with pinhole of 1 airy unit were recorded, 
with the section spacing of 150 nm. Threshold-based colocalization was per-
formed on the three-dimensional datasets using the Definiens Software Suite 
(Definiens AG). Fixed thresholds were used to determine the green, red, and 
colocalizing population.
For colocalization analysis of phagocytosed cy3-CpG-DNA with CD14 in 
RAW264.7 macrophages, a confocal microscope (TCS SP5; Leica) with a 63× 
oil immersion objective (Leica) was used. Fluorochromes were excited using an 
argon laser at 488 nm and a HeNe laser at 568 nm for Texas red. Detector slits 
were configured to minimize any cross talk between the channels. Z stacks (op-
tical sections) of the images were collected with an optical thickness of 0.2 mm. 
Images were processed using the LAS system software (Leica).
All other pictures were taken with a microscope (Eclipse 80i; Nikon) with 
a Plan-Fluor 40× objective (Nikon) with a numerical aperture of 0.75. All   
images were processed with Photoshop (Adobe) and assembled in Illustrator 
software (Adobe) with identical processing for all images in one experiment.
Online supplemental material. Fig. S1 shows representative silver stain 
gels of the TLR TAP eluates and the peptides of CD14 that were detected by 
MS. Fig. S2 contains several lines of evidence that the TLR ligands imiqui-
mod and CpG-DNA were endotoxin free. Fig. S3 shows the requirement of 
CD14 for IL-6 production upon CpG and imiquimod stimulation in perito-
neal macrophages. Fig. S4 shows inhibition of IL-6 levels upon addition of an 
inhibitory CD14 antibody to WT BMDCs before stimulation with imiqui-
mod and also shows that cy3-CpG is sufficiently taken up into early and late 
endosomes of RAW264.7 macrophages. Fig. S5 shows the relative adhesion 
of free cy3-CpG-DNA to WT or CD14/ peritoneal macrophages. Fig. S6 
shows that VSV titers are equally high after infection of BMDCs, that VSV 
and FluAV recognition in macrophages depends on CD14 and can be inhib-
ited in WT cells with a CD14-specific antibody, and that the protease inhibi-
tor z-FA-FMK decreases the proinflammatory response to VSV and FluAV 
but not LPS. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20101111/DC1.
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abundance of murine IL-6 and TNF was analyzed using SYBR green   
(GeneXPress)  and  the  following  primers:  IL-6  5,  5-TTCCATCCAG-
TTGCCTTCTT-3;  IL-6  3,  5-ATTTCCACGATTTCCCAGAG-3; 
TNF 5, 5-CAAAATTCGAGTGACAAGCCTG-3; TNF 3, 5-GAGA-
TCCATGCCGTTGGC-3; cyclophilin B 5, 5-CAGCAAGTTCCATC-
GTGTCATCAAGG-3; and cyclophilin B 3, 5-GGAAGCGCTCAC-
CATAGATGCTC-3. Quantitative real-time PCR analysis was performed 
on a Rotor Gene 6000 (QIAGEN). Measured TNF and IL-6 cycles were 
normalized to the ones of cyclophilin B.
In vivo experimental procedures. Pathogen-free 9–11-wk-old female 
C57BL/6J  (breeding  facility  of  the  Medical  University  of Vienna)  and 
B6.129S-Cd14tm1Frm/J CD14/ were used in all in vivo experiments, which 
were approved by the Animal Care and Use Committee of the Medical Uni-
versity of  Vienna. Mice were injected i.p. with 8 nmol CpG-DNA and 20 mg 
DGALN (Sigma-Aldrich) in 200 µl of saline per mouse. After 4 h, mice were 
sacrificed, and peritoneal lavage was taken. Cell counts were determined on 
each peritoneal lavage sample stained with Turks solution, and differential cell 
counts were performed on cytospin samples stained with Giemsa.
Phagocytosis assay and FACS. For analysis of phagocytosis of fluorescent 
DNA, either RAW264.7 or peritoneal macrophages were plated at a density 
of 106 on 6-well plates. 1 µM cy3-CpG-DNA was added to the cell culture 
medium for the indicated time points. 1 well of each cell type was shifted to 
4°C before the addition of oligonucleotides and served as a phagocytosis-
negative control. After three washes with ice cold PBS, cells were harvested 
and resuspended in PBS, and cy3-positive/F4-80–positive cells were analyzed 
on a FACSCalibur flow cytometer (BD). A set of 20,000 gated cells was ana-
lyzed for their GMI (geometric mean intensity of Cy3 fluorescence). The 
phagocytoid index was calculated as follows: GMI sample × amount of gated 
cells  GMI 4°C control × amount of gated cells.
Immunoprecipitation  and Western  blotting.  1.5  ×  109  RAW264.7 
macrophages per endosomal TLR construct have been used for TAP. All steps 
have been performed as described in Bürckstümmer et al. (2006), despite the 
use of lysis buffer (50 mM Tris-HCl, pH 6, 150 mM NaCl, 1 mM EDTA, 
7.5% glycerol, 25 mM NaF, 0.2% NP-40, 1 mM DTT, and 1 mM Na3VO4, 
adjusted to pH 6.0 with HCl).
Immunoprecipitation of tagged TLRs and CD14 was performed as fol-
lows: 6 × 106 Hek293T cells were seeded on 10-cm dishes and double trans-
fected with 7.5 µg of plasmid DNA encoding human CD14-myc and 7.5 µg 
of plasmid DNA encoding either the C-terminally V5-tagged human TLR3, 
TLR7, TLR8, or TLR9 or IL-1R protein. 48 h later, cells were lysed with   
lysis buffer (1% NP40, 20 mM Tris-Hcl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 
and 5 mM EGTA), and the soluble lysate was used for immunoprecipitation 
using  V5 agarose (Sigma-Aldrich). After a 2-h incubation of beads on a rotat-
ing wheel for 2 h, beads were washed four times with cold lysis buffer and 
taken in Laemmli buffer. Boiled eluates were run on SDS-PAGE and trans-
ferred on membranes by Western blotting. V5 and myc epitopes were visual-
ized by Western blotting and detected using an Odyssey system (LI-COR 
Biosciences). For immunoprecipitation of endogenous CD14, biotinylated 
CpG-DNA or GpC-DNA or biotinylated LPS was coupled to streptavidin 
beads and washed twice before incubation with RAW264.7 macrophage ly-
sates. After a 2-h incubation at 4°C on a rotating wheel, beads were washed 
four times with lysis buffer and taken and boiled in Laemmli buffer. Precipi-
tation of endogenous CD14 and Trex1 was analyzed by Western blotting   
using anti-CD14 and anti-Trex1 antibodies. To investigate the specificity   
of  recombinant  CD14  to  CpG-DNA,  streptavidin-coated  96-well  plates 
(Thermo Fisher Scientific) were coated with biotinylated CpG-DNA 
overnight. After three washes of the plates with PBS/0.1% Tween, the 
wells were incubated with the indicated amounts of Fc-CD14 chimera 
(R&D Systems) and LPS competitor for 2 h. After three washes, bound 
CD14 was incubated with anti–mouse horseradish peroxidase antibody and, 
after another five washes of the plates, detected with tetramethylbenzidine 
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